US-based medical device manufacturer Boston Scientific has introduced fiXate Tissue Band in the US. The product, which was purchased from Anulex Technologies, is a suturing device that is designed to enable simple placement of a suture to ...
Tags: Boston Scientific, Fixate Tissue
Munich American Reassurance has introduced new key enhancements to its EDGE Life and Disability Income (DI) underwriting manuals, during the Association of Home Office Underwriters (AHOU) 12th Annual Conference. The manuals' enhancements ...
Tags: Munich Re, Underwriting Manuals
BioDelivery Sciences International and Arcion Therapeutics have signed a worldwide licensing deal for the development and commercialization of topical clonidine gel (previously ARC4558) to treat painful diabetic neuropathy (PDN) and other ...
Tags: BioDelivery, Arcion Therapeutics, topical clonidine gel development
Some common Chinese herbal remedies contain aristolochic acid, which has been linked to kidney disease and cancer. And despite efforts by the Food and Drug Administration to keep the ingredient out of herbal products sold in this country, ...
End Discrimination Now issued a highly critical statement regarding the new prescription drugs laws approved this week by the NYS Senate. Characterizing the “new” law as “alarmist”, “excessive” and ...
Braeburn, a subsidiary of Apple Tree Partners, has gained commercialization rights to Titan Pharmaceuticals' long-acting subdermal implant in the US and Canada, under the signed license agreement. The investigational subcutaneous implant, ...
Tags: Braeburn, Marketing Rights, subsidiary of Apple Tree Partners, Medicine
ICAP Patent Brokerage,a provider of post trade risk and information services,has announced for sale a patented multi-purpose topical analgesic cream,designed for treating arthritis,other chronic pain syndromes as well as muscle ...
Tags: ICAP, analgesic cream, MyoRX
The US Food and Drug Administration (FDA) has granted 510(k) clearance to NeuroMetrix's Sensus pain management system, designed as a treatment for painful diabetic neuropathy. The Sensus system is designed for use as a non-invasive ...
OneSource Medical Group in Florida has entered into an agreement to distribute NeuroMetrix's transcutaneous electrical nerve stimulator, designed to help manage chronic pain in diabetes patients with painful diabetic neuropathy. The ...
Tags: OneSource, agreement, NeuroMetrix
Boston Scientific has obtained CE mark approval for its spinal cord stimulator(SCS)system with 32 contacts and 32 dedicated power sources. The Precision Spectra system,which has four lead ports offering more coverage of the spinal cord,is ...
Tags: Boston Scientific, CE mark approval, SCS system, spinal cord
The FDA has accepted the review of Zogenix new drug application (NDA) for Zohydro ER (hydrocodone bitartrate extended-release capsules) for the treatment of moderate to severe chronic pain. Zohydro ER is an oral, single-entity (without ...
Tags: Zohydro ER, hydrocodone bitartrate extended-release capsules
Biopharmaceutical company Zalicus has received the US FDA approval for its supplemental new drug application (sNDA) for the 32 mg dose strength of Exalgo(hydromorphone HCl) Extended-Release Tablets (CII). Exalgo is used to treat moderate ...
Tags: Exalgo Extended-Release Tablets, around-the-clock opioid analgesia
Perrigo Company, a healthcare company, has won final FDA approval for its abbreviated new drug application for morphine sulfate 100ml/5% oral solution. Perrigo will immediately begin the shipment of Morphine sulfate oral solution, a ...
Tags: Perrigo Company, morphine sulfate, morphine sulfate oral solution
Cara Therapeutics and Chong Kun Dang Pharmaceutical have signed licensing contract to develop and market CR845, an analgesic drug candidate, in the Republic of Korea. As a part of the agreement, Cara is eligible to gain an up-front ...
Tags: analgesic drug candidate, licensing contract, CR845, Cara Therapeutics
Orexo and ProStrakan Group have reconfigured the commercial rights to the product, Abstral, in various territories worldwide. Abstral is the novel, rapidly-disintegrating, sublingual (under the tongue) formulation of fentanyl, and an ...